AnteoTech Limited (ADO) Earnings Call Transcript & Summary
April 29, 2025
Earnings Call Speaker Segments
Simon Hinsley
unknownMorning everyone, and thanks for joining AnteoTech's investor webinar. We've got Merrill Gray with us — she's the Interim Managing Director and CEO. <<operator_script>> One quick note: Merrill has only been in the role for the whole week — it's her first week in the office. So we'll try to get through as many questions as we can. Just keep in mind that, as outlined in the quarterly today, a strategic review is currently underway. So please bear that in mind. With that said, Merrill, I'll pass things over to you for an introduction. Thanks.
Merrill Gray
executiveThank you, Simon. First off, I want to acknowledge that a great deal has changed. As Simon mentioned, this is my first week in the office, so please forgive me if I can't address some of the questions that come through with the depth of detail they deserve. But my intention is to be able to do that very soon. I was adamant that we needed to hold this webinar to really demonstrate that we're aiming for greater transparency and clear communications with shareholders. It's a different Board now, and the past Board members and executives certainly did a good job and gave their very best in terms of the challenges we're facing in the market, which are very real. And I would like to thank you — that's a really important message at the outset. Thank you for your support. Thank you for engaging. And I look forward to going through as much as I possibly can, as Simon said, while we go through a strategic review and can come out to you more fulsomely with what we're planning to do. So I'll hand back to Simon.
Simon Hinsley
unknownOkay, thanks, Merrill. So to begin with, let's get going once more. Quite a few of these questions came in. We've combined several of them where they overlapped and summarized. So please excuse us for doing that. But our starting point will be battery metals, or battery materials, and in particular the present performance in technical data, Merrill. Could you just speak to the most recent performance results for Ultranode, and in particular the data at defined silicon percentages?
Merrill Gray
executiveYes. Great. Okay. So our quarterly report is out, and it contains that clear target: 800 cycles at 80% capacity retention. And naturally, our focus is the 70% high silicon anode. Now, I'd like to begin those remarks by being clear that, yes, obviously, we have not delivered on the commitments made previously, which are 1,000 cycles at that same capacity. But we're not giving up. And I'll say a bit more about that. So what we're really — what we're aiming to do is truly capitalize on the work done to date. Now it's clear to us that more investment is required to reach where we need to go. But by breaking that out into building a product around what we already have, which suits different markets on the consumer side and the e-mobility side, and really finding a partner that is on the same page and strategically aligned with us — that's where we're looking to go. We'll have more on that in the future, obviously. And then on the high-performance side, we see that it's something we'll need to step towards.
Merrill Gray
executiveSo this morning we actually put a fact sheet up on the website — you could call it a corporate flyer — and it's sitting on one of the front pages and definitely among the brochures, and it walks through in a bit more detail what it is we do and where we're heading with both of our divisions, so life sciences and the advanced battery materials — the battery technology group. So productizing, commercializing, and making sure we actually get into those unique or slightly more niche markets — that's the direction we're going. There were some questions regarding pouch cells. And yes, multiple parties have tested them in the past. And just a reminder that Mercedes-Benz is the one party doing pouch cell testing. There were also questions about full cell. So I guess a really important part of what we hope to come back with is around how we are engaging on in the value chain with commercial partners. So the answer is yes, pouch cells — we have — we are doing coin testing, but we are doing pouch cell testing. It has been done in the past. And with some new formulations around the Ultranode that we're currently testing and where we want to go, that is being tested.
Merrill Gray
executiveI suppose the key takeaway is that additional details will emerge once we have them. I want to expand more thoroughly on a few of the more commercial questions that came up regarding advanced battery technology for the battery technologies group. So there is real market interest. And as we noted in the quarterly, we have been in discussions with 3 global chemicals companies. The important thing for us is to try to convert that in a manner that creates value for all involved. So that is -- and plenty of other parties are in fact assessing our product, as everyone is aware, but it comes down to ensuring we truly reach the point where the value proposition works and ensuring our partners are strongly committed and motivated to make the change. It is a very difficult market in which to do deals. We are not alone in new technologies confronting that. But naturally, my mandate coming in is to be really, really commercial in how we approach that. And I just want to -- everyone knows that. But I must mention that in a bespoke market where standards do not actually exist around manufacturing processes for coin cell, cylindricals, prismatics and pouches, it is a highly bespoke process we have been working through, a minimum of 6 months for people to validate the technology up to 2 years.
Merrill Gray
executiveWhat we're doing is taking a hard look at how we sell and refining the overall value proposition, so we can move faster on working with companies that share our outlook. Bringing a genuinely commercial emphasis is what I plan to contribute in this position. Over to you, Simon.
Simon Hinsley
unknownAlright, thank you, Merrill. To be specific, I just want to be sure we get the questions asked. In what way does Anteo engage when working with end user clients and the independent battery manufacturers they use, for instance, and in how it assesses both Anteo X and the AnteoTech entrepreneur? Is Mercedes-Benz sharing its finance with the suppliers of its batteries?
Merrill Gray
executiveThat's a great question. So the relationship with Mercedes-Benz, and where we want it to go, is centered on exactly that—validation in their lab, which is what they asked for so it can then be shared with the party they intend to partner with. And this is a genuinely hard piece, a genuinely hard piece of what we do: managing the geopolitical side, the sustainability side, a whole set of frameworks, how organizations transition to them, and how that actually gets delivered inside the European Union, for instance. So the answer is we understand that they do. Exactly who that is, how we secure the introductions, and how we actually get placed into their future designs and their production schedules—that's where things stand with Mercedes. So that's what we hope to gain from the relationship. We have further discussions in June, and we will absolutely keep them tightly focused and very much on how all of this works and how we can make it happen. I really want to be clear that for the likes of—and I won't talk specifically about Mercedes-Benz, but really for European car manufacturers—Chinese battery supply is the whole ballgame.
Merrill Gray
executiveSo how that plays out in commercial terms—it's genuinely commercial, extremely commercial—they're sharply focused, from a commercial standpoint, on battery makers outside China, and on how the various technologies fit together, and on how long different carmakers will keep doing what they currently do, which is inserting Chinese parts into their EVs. That's a far broader economic and regulatory framework, if you will, that we have to operate inside. So it may not be widely appreciated just how much componentry there is and how it originates from China, and that's the competition we face. It's extremely significant.
Simon Hinsley
unknownThanks. I’d like to ask how much Anteo X has supplied to Mercedes-Benz for manufacturing trials, and where things stand on a design and a final decision.
Merrill Gray
executiveRight, so that's precisely the point I was making a moment ago. Anteo X, then, is one element within the broader design. Volumes are very small, intended for laboratory-scale testing. As for Mercedes — and you really need to keep this in mind — they belong to ACC, the group built around establishing gigafactories in Europe, and that footing is unsteady. So we're somewhat ahead of where Mercedes — it's just like the previous question, namely how do we get inside that system, where an update is needed and we have to learn what's actually going on. Plenty of people are now posing the very same questions we are. That will emerge through our strategy regarding how we expect to capitalize on the work already done with Mercedes and where the situation is moving. It's simply a little early for us to state that, given the strategic review.
Simon Hinsley
unknownThanks. I just have one question about how things are going on the commercial side. How much headway have you made with the other big electric vehicle companies?
Merrill Gray
executiveYes. I believe we've made it fairly clear previously that our discussions with OEMs have been — and honestly, everyone knows those OEM conversations have been in the works. When putting together the quarterly report, I wanted to state plainly that there's been a degree of pullback in commitments regarding the direction things are heading, especially on the high silicon side. We have to stay aware of market conditions, remain flexible, and build out options that truly build on the work we've completed so far. So it isn't that they're disappearing. It's simply that progress is slower. And as a small company based in Australia, we must be adaptable, quick on our feet, and figure out how to get into systems tied to e-mobility, for instance, which might be moving more quickly right now. So that's the whole — that's everything currently being examined as part of the strategy review.
Simon Hinsley
unknownAnd one more question, this time about how things are progressing commercially with consumer electronics firms. I know you mentioned—to borrow the phrase—e-bikes and so on, but where does that currently stand as well?
Merrill Gray
executiveYes. No, no. Clearly, our VP of Sales, Fabian Beck, is based in Germany, and through his time at VARTA plus his contacts there, he brings quite a deep background in consumer batteries. So yes, that’s an area that, once again, when we roll out our strategy more fully, we’re examining closely via relationships, networks, and also wherever we can move in as quickly as possible. And again, the time required for validation, for a new design, going back to the earlier question, which concerns manufacturing — getting into the manufacturing process. There is — a time frame is involved there. And as I mentioned earlier, 6 months minimum, 2 years to fully validate. So how can we get around that with customers already further up the learning curve, where those processes can be sped up. So the answer is yes, it is a focus.
Simon Hinsley
unknownAnd then just a couple last questions about commercial progress, specifically regarding chemical companies and carbon nanotube companies.
Merrill Gray
executiveYeah, carbon nanotubing. So I think what I've already explained is that we're taking on board the context of the markets that we're working in, and that relates to how could we diversify, and that's what this question is really about. In the chemicals companies, this is a big focus. And as we've said in the quarterly, we're engaging with 3 global companies who all already supply into battery manufacturers because again, this is about what can we do as a small company with our expertise and our networks. So by leveraging off that and your established customer base and your testing programs and Anteo X being added into those testing programs is what we're seeking to do through distributorships and partnerships, and that's where we're going. So chemical companies, in particular, who are already -- who are great quantums larger than us who are already established, as I said in the quarterly, we're already engaging with them, and we're looking to do that further. Diversification, I guess, I've already referred to that, is something we're looking at, yes.
Simon Hinsley
unknownThanks. Let's turn now to strategy around sales and commercial results. Here's a question: since earlier guidance pointed to commercial deals being imminent, why haven't signed contracts shown up yet? And which particular obstacles have come up?
Merrill Gray
executiveYes. Okay. So this is — I have — as part of stepping into this role, I've obviously gone out to my contacts across the sector to ask about the current situation — in various areas of the battery componentry and what they're seeing, how it's growing for them. And it's not great for our shareholders to hear that we're not alone. It's a very challenging market for people to be making deals around new technologies and the progress that needs to be made in batteries. With EVs being — the competition around Chinese EVs, Chinese technology, and we get a lot of comments about how Chinese technology change is going to impact us. We obviously have a watching brief on that. And they are going to impact everybody in the market. So we need to constantly be looking at how do we fit in, how do we move forward as fast as possible, how do we secure a position. So that comes back to commercially, we've been asked some of these questions, why is it taking so long? And why are we not seeing what's expected in terms of commercial outcomes? It's not because we're not engaging and getting to a certain point, but actually getting it across the line is a time frame that is sometimes not in our court.
Merrill Gray
executiveThat involves other parties that have their own separate issues to deal with. And our end customers are also up against a really difficult market when it comes to their flexibility and their ability to move quickly. So there's no single cause, no one particular reason. We follow standard processes. But what I can say is that I recognize that expectation exists, and the frustration as well, but every avenue and every possibility is something we're pursuing. So my focus on this...
Simon Hinsley
unknownNo, and again — you're only 1 week in, Merrill, and since the aim is to get through as many of the submitted questions as possible, I think you're doing a great job. So we'll keep going just around — at what point would AnteoTech consider walking away from "tire kickers" to focus on serious partners?
Merrill Gray
executiveAll right, so that’s a genuinely strong question, and it matters a great deal that our quite constrained resources get deployed as effectively as possible. As was mentioned, this is my first week in the role, and I’ve been sitting down with the head of every division and with people across the team to grasp the way choices get made about which things we pursue, and how we pull out when something fails to reach a certain threshold—since the pipeline matters here too. My hope is that I can contribute some of the contacts I built while working in cathode active materials and through my experience in recycling, including some of that around ensuring we hold high-level commercial conversations as early as we can, and that where there isn’t a clear shared commercial value proposition that everyone has signed up to, we move on—because stocking that pipeline with opportunities is something we will be concentrating on heavily over the next month or so.
Simon Hinsley
unknownThanks. Now, regarding funding and grants — when does AnteoTech anticipate the money from QIC and ARENA coming in?
Merrill Gray
executiveYes. All right. So that, as everybody is aware, is matching funds, and it will likewise depend on how the strategy shakes out. So please be patient with me on that one, since we want to do everything sensible when it comes to rolling out our products and commercialization. So please be patient on that, we are still reviewing it. And I suppose — yes, so Simon, I guess that could also carry over into life sciences. So I will leave that one to you.
Simon Hinsley
unknownRight, so that brings us to the next question, and it concerns the Serum Institute of India. Are they buying AnteoBind at a pace that exceeds the minimum set out in the agreement?
Merrill Gray
executiveYes. So yeah, their AnteoBind run rate is exceeding what we had expected. And as a matter of fact, they have consumed the entire 12 — what we initially sold them for the 12 months within 6 months. So we're expecting additional orders to come in. In fact, a visit recently took place to sit down with them, and they are also planning to come and see us. Now that relates to usage, but they are also working on — they are branching out into new tests. So lateral flow-based tests are in development. And what's great about our Serum Institute relationship is that they have connected us with other parties who are likewise creating new tests. So I would say we are genuinely looking forward to meeting with them here at the office and strengthening that relationship.
Simon Hinsley
unknownAnd one more question on how AnteoBind's use has been spread across the Serum Institute of India's product lines. Has that been accomplished?
Merrill Gray
executiveRight, so that ties back to the lateral flow test and the other tests they're aiming to move into. Naturally, I'd say that once clinical trials are done and we get into testing, that will lead on to production at a larger scale. That's a nice segue, maybe, into Vidcare and where things stand with Vidcare. I know there are a few questions on that as well. So that's where we are — with Vidcare, we're in testing. And there's been genuinely serious engagement, and that relationship has deepened too. So there's — the team is out in India for 2 weeks doing optimization and assay technology training. And where we've got to there is that we're waiting for testing to be finished so we can go into clinical trials, which is the precursor for us to then move into larger — for approval so we can then move into production at a larger scale. So I know there were some questions about where we're up to and when all of that is going to happen. It's basically an ASAP-type situation. So everything going through that stage process is being watched by the team and managed on a daily basis.
Simon Hinsley
unknownMoving to expansion plans, I have a question on that front. Which kinds of opportunities has Gautam and the life science team pinpointed across Australia, India, Europe, and the U.S.?
Merrill Gray
executiveYeah. So quite a few high-value research groups are in the process of evaluating AnteoBind. Some of them sit in the medical device space, for those specifically interested in what we're doing on the life sciences side. And we — as part of the strategy, we're also examining how to deepen and broaden our distributor relationships and our opportunity-finding efforts. So there's a whole piece we're trying to pull together, and we'll be able to communicate more fully on that. But the last trip did expand our pipeline. And I guess the one really key message Gautam has shared with me is that they're very — the people we're working with are very well credentialed, very well regarded. This is part of our process — which someone asked about again regarding tire kicking, part of our process of making sure we're working with the right parties to really get us into the system and up and running.
Simon Hinsley
unknownAnd just one last question about life sciences. In what way does the team intend to tackle these opportunities and expand the customer base?
Merrill Gray
executiveAbsolutely. That falls under the strategy review as well — once again, it's about making sure that team is rightsized, that the right skills are in place within it, and that we're fully clear on which opportunities we intend to pursue.
Simon Hinsley
unknownGreat. And as we move into more of a discussion with the corporate and sales commercial team, could we get an update on how Fabian Beck is progressing in his role as VP of International Sales?
Merrill Gray
executiveYes, great. Yes. Fabian and I have been speaking quite regularly while we've worked through these changes. And honestly, it's really wonderful to have him with us and to find that we share very similar views on where some opportunities might be. So we'll lean heavily on him and his deep networks as we decide where to go next. We're very, very happy to have him and to be able to draw on his networks and his knowledge base.
Simon Hinsley
unknownI realize a strategic review is currently in progress. That likely connects to what I'm about to ask, but do you plan to examine staffing levels and expenses in light of performance?
Merrill Gray
executiveCertainly. Looking at the strategic review, it spans all areas — from expenses and income sources, which we've discussed, namely the marketing, sales, and communication side of things. And as we've already mentioned, that also covers investment. So when it comes to customers, certain ones we're speaking with, especially chemical companies and battery materials companies, could likewise be strategic parties that we're aiming to engage with. So it touches cost, revenue, and investment, plus how we manage our overall resource base and our cash flow. So the answer is that nothing is off the table, and we intend to be able to come to the market very shortly with how we've altered things or how we've reorganized things.
Simon Hinsley
unknownLet me swing back to intellectual property for a moment so we make sure that's covered too. What's the expected timing for the Ultranode patents to be granted?
Merrill Gray
executiveOn that one — apologies, I don't have an answer right now; I'll revisit it.
Simon Hinsley
unknownThat's fine. Once more, if there's any question we haven't fully addressed, or if you have additional questions, we're more than happy to take e-mails and follow up on them. So apologies if we don't manage to reach everything. Merrill is doing her very best. We'll follow up on that too. And once more, we'll follow up on any feedback regarding the patent lawyers they've provided, as well as some of the discussions about Anteo X being registered under REACH. But if we could now turn to the company's website, company image and operations, when will that be updated and approved? I can probably take that one. We're currently working overtime to update it and make sure it reflects the current operations. So stand by and keep an eye on that. But probably more for you, Merrill, on shareholder communication: can shareholders expect clearer and more frequent updates on the true state of commercial prospects?
Merrill Gray
executiveYes. That is really helpful. This is likely a good moment for me to return to the topic and make certain I state it plainly. Now a different Board is in place. And we are strongly dedicated to open communication with shareholders and to enhancing how we communicate overall in marketing and sales with prospective customers. And as I mentioned, we released a brochure this morning, which is a general brochure, and we have conferences approaching, 3 that we intend to — which is also covered in the quarterly, which we intend to attend and are working hard on our collateral and the connections we can gain from that. But really concentrating — concentrating our message on what we offer and the extremely significant gains that Anteo X can provide, along with collaborating with partners regarding where Ultranode can fit within manufacturing processes. So as I have already noted, I look forward to returning more fully with a strategy that we intend to carry out. And we are very much looking forward to engaging. We have our Investor Relations e-mail so anyone can send in questions they have that were not answered today or ongoing questions. And I would really like to thank you once more.
Merrill Gray
executiveI want to express appreciation to all of you joining this call and to every one of our shareholders for standing behind us. And we genuinely look forward — I'm not sure how to phrase this any better — to diving in wholeheartedly and being deeply dedicated to creating shareholder value.
Simon Hinsley
unknownThank you. It has been thorough. As I mentioned at the outset, since Merrill is just beginning, we wanted to make sure we asked and covered as many potential questions as we could. So hopefully we've managed that. If not, as Merrill said, we're more than happy to receive any questions you submit by e-mail, and we'll try to respond to them over the next few days. I think the only other item I'll touch on is that we intend to share a bit more via the mail-out system we have in place, regarding various conferences we'll be attending and the presentations included with those. We'll make an effort to keep shareholders informed so they're up to date. But Merrill, well done. And if any other questions come up, as I said, please just send them in. Thanks, everyone, for joining. There's a lot on the call. And Merrill, well done once more. Thank you very much.
Merrill Gray
executiveThanks. Thanks to all of you.
Simon Hinsley
unknownI appreciate it.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete AnteoTech Limited transcript — plus 133,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to AnteoTech Limited earnings transcripts and 133,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in AnteoTech Limited or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.